Inflammatory bowel disease (IBD) encompasses ulcerative colitis, Crohn's disease, and indeterminate colitis, characterized by inappropriate immune activation to intestinal microflora. With rising incidence particularly in Western nations, IBD presents through various clinical features including diarrhea, abdominal pain, and more severe complications like toxic megacolon and cancer risk. Genetic, environmental, and immunological factors contribute to the etiology and pathophysiology of these chronic conditions.